My watch list
my.bionity.com  
Login  

When Food met Pharma: Delivery Strategies for Nutraceuticals

With growing prevalence of lifestyle-associated diseases, including obesity, Type II diabetes and cardiovascular disease, there is an urgent need and demand to try to prevent the onset of these diseases within our growing population. Nutraceuticals, along with appropriate diet and exercise, may provide a solution. They are defined as bioactive compounds isolated from food which provide a physiological benefit beyond basic nutrition. However, many of these useful components will not yield their potential efficacy without appropriate oral delivery technologies.

Recently researchers have been leveraging technologies which were applied to delivering drugs in the pharmaceutical industry. This includes nano-sized delivery vehicles and absorption enhancers. These are key areas for developing nutraceutical solutions to managing disease prevention at an early stage, prior to therapeutic intervention.

Join John Gleeson as he explores the different types of nanoparticles currently being investigated to deliver food components and whether there is need or benefit to these tiny delivery vehicles. Outlining the current research, he'll investigate how scientists deliver these nutraceuticals from your mouth, through the obstacle course that is your digestive tract, to the right destination, without disrupting their potential health benefits.

Topics:
More about Royal Society of Chemistry
  • Videos

    Everest Lab: The Science Of High Altitude Survival

    What happens to your body when you push it to somewhere it’s not built to go – to the top of the world?With summit kit, interactive experiments & stunning videos from his trek to the highest lab in the world at Everest Base Camp, join TV & YouTube Science Presenter Greg Foot to find out.Gre ... more

  • News

    Therapeutic screening for Alzheimer’s disease

    Scientists in Canada and the United States have developed a chip sensor for monitoring how drug candidates alter amyloid-β peptide aggregation that they hope could be used to find new treatments for Alzheimer’s disease. Research into Alzheimer’s disease has shown that the self-aggregation o ... more

    Using bacteria to make electrodes

    Scientists in France have produced hematite using a bacterial pathway for use as an electrode material in Li-ion technologies. Currently, most commercial electrode materials for Li-ion technologies are prepared using the ceramic method, which requires long heating periods at high temperatur ... more

    Moving the MRI goalposts

    Scientists in the UK have developed a new class of MRI (magnetic resonance imaging) agents that promise to deliver clearer images more quickly. Chemical shifts from proton NMR normally fall between 0-12ppm, but water and fat resonate at 4.7 and 1.3ppm respectively, causing noise that can ov ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE